Haemonetics
HAE
#3927
Rank
A$4.54 B
Marketcap
A$94.39
Share price
1.59%
Change (1 day)
-11.29%
Change (1 year)

Haemonetics (HAE) - P/B ratio

P/B ratio as of February 2026 : 3.73

According to Haemonetics's latest financial reports the company has a price-to-book ratio of 2.38265.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Haemonetics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-314.545.62%
2024-12-314.30-6.6%
2023-12-314.60-10.33%
2022-12-315.1338.29%
2021-12-313.71-55.76%
2020-12-318.38-16.79%
2019-12-3110.127.03%
2018-12-317.93112.77%
2017-12-313.7338.4%
2016-12-312.6918.35%
2015-12-312.28-1.49%
2014-12-312.31-12.78%
2013-12-312.65-2.13%
2012-12-312.7124.81%
2011-12-312.17-10.05%
2010-12-312.41-0.28%
2009-12-312.42-13.21%
2008-12-312.79-18.27%
2007-12-313.4129.93%
2006-12-312.62-15.43%
2005-12-313.1011.18%
2004-12-312.7923.95%
2003-12-312.25-4.25%
2002-12-312.35

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.16 92.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
2.69-27.89%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
4.15 11.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
1.49-59.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
2.35-36.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
6.41 72.08%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
1.80-51.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus
CERS
6.99 87.73%๐Ÿ‡บ๐Ÿ‡ธ USA